thioctic acid has been researched along with Blood Poisoning in 15 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
Excerpt | Relevance | Reference |
---|---|---|
"Sepsis is a life-threatening immune disorder resulting from an dysregulated host response to infection." | 3.30 | Adjuvant Lipoic acid Injection in Sepsis treatment in China (ALIS study): protocol for a randomised, single-blind, placebo-controlled trial. ( Chen, C; Chen, X; He, Y; Hu, L; Huang, J; Huang, X; Li, S; Wang, G; Wu, K; Wu, Q; Zhou, X, 2023) |
"Sepsis is a complication of an infection which imbalance the normal regulation of several organ systems, including the central nervous system (CNS)." | 1.46 | Alpha-lipoic acid attenuates acute neuroinflammation and long-term cognitive impairment after polymicrobial sepsis. ( Barichello, T; Bellettini-Santos, T; Budni, J; da Rosa, N; Dal-Pizzol, F; Danielski, LG; Della Giustina, A; Fileti, ME; Florentino, D; Fortunato, JJ; Garbossa, L; Goldim, MP; Martins Laurentino, AO; Mathias, K; Mina, F; Oliveira Junior, AN; Petronilho, F; Zarbato, GF, 2017) |
"Sepsis is often initiated by invasive infection, characterized by overwhelming induction of pro-inflammatory cytokines." | 1.42 | Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-κB) signaling pathway. ( Fu, J; Ji, K; Li, G; Luan, T; Zang, B; Zhao, Y, 2015) |
"Acute kidney injury is a frequent and serious complication in patients with severe sepsis." | 1.40 | α-Lipoic acid prolongs survival and attenuates acute kidney injury in a rat model of sepsis. ( Chen, W; Gao, L; Gong, X; Jia, J; Li, G; Zang, B, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 9 (60.00) | 24.3611 |
2020's | 3 (20.00) | 2.80 |
Authors | Studies |
---|---|
Hu, L | 1 |
Zhou, X | 1 |
Huang, J | 1 |
He, Y | 1 |
Wu, Q | 1 |
Huang, X | 1 |
Wu, K | 1 |
Wang, G | 1 |
Li, S | 1 |
Chen, X | 1 |
Chen, C | 1 |
Giustina, AD | 1 |
de Souza Goldim, MP | 1 |
Danielski, LG | 3 |
Garbossa, L | 2 |
Junior, ANO | 1 |
Cidreira, T | 1 |
Denicol, T | 1 |
Bonfante, S | 2 |
da Rosa, N | 2 |
Fortunato, JJ | 2 |
Palandi, J | 1 |
de Oliveira, BH | 1 |
Martins, DF | 1 |
Bobinski, F | 1 |
Garcez, M | 1 |
Bellettini-Santos, T | 2 |
Budni, J | 2 |
Colpo, G | 1 |
Scaini, G | 1 |
Giridharan, VV | 1 |
Barichello, T | 2 |
Petronilho, F | 3 |
Pagano, G | 1 |
Manfredi, C | 1 |
Pallardó, FV | 1 |
Lyakhovich, A | 1 |
Tiano, L | 1 |
Trifuoggi, M | 1 |
Della Giustina, A | 1 |
Goldim, MP | 2 |
Florentino, D | 2 |
Mathias, K | 1 |
Oliveira Junior, AN | 1 |
Fileti, ME | 1 |
Zarbato, GF | 1 |
Martins Laurentino, AO | 1 |
Mina, F | 1 |
Dal-Pizzol, F | 1 |
Jia, J | 2 |
Gong, X | 2 |
Zhao, Y | 2 |
Yang, Z | 1 |
Ji, K | 2 |
Luan, T | 2 |
Zang, B | 3 |
Li, G | 3 |
Hiller, S | 1 |
DeKroon, R | 1 |
Xu, L | 2 |
Robinette, J | 1 |
Winnik, W | 1 |
Alzate, O | 1 |
Simington, S | 1 |
Maeda, N | 2 |
Yi, X | 2 |
Gao, L | 1 |
Chen, W | 1 |
Fu, J | 1 |
Shen, HH | 1 |
Lam, KK | 1 |
Cheng, PY | 1 |
Kung, CW | 1 |
Chen, SY | 1 |
Lin, PC | 1 |
Chung, MT | 1 |
Lee, YM | 1 |
Vieira, LC | 1 |
Martins, MM | 1 |
Vieira, A | 1 |
Vuolo, F | 1 |
Zorzoli, A | 1 |
Grayczyk, JP | 1 |
Alonzo, F | 1 |
Kim, K | 1 |
Yuan, W | 1 |
Kim, HS | 1 |
Homeister, JW | 1 |
Key, NS | 1 |
Vanasco, V | 1 |
Cimolai, MC | 1 |
Evelson, P | 1 |
Alvarez, S | 1 |
Cadirci, E | 1 |
Altunkaynak, BZ | 1 |
Halici, Z | 1 |
Odabasoglu, F | 1 |
Uyanik, MH | 1 |
Gundogdu, C | 1 |
Suleyman, H | 1 |
Halici, M | 1 |
Albayrak, M | 1 |
Unal, B | 1 |
Zhang, WJ | 1 |
Wei, H | 1 |
Hagen, T | 1 |
Frei, B | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effect of Alpha-Lipoic Acid on the Clinical Outcome of Patients With Sepsis[NCT05808946] | Phase 2/Phase 3 | 60 participants (Anticipated) | Interventional | 2023-03-10 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for thioctic acid and Blood Poisoning
Article | Year |
---|---|
Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Carnitine; Chemotherapy, Adjuvant; COVID-19 Drug T | 2021 |
1 trial available for thioctic acid and Blood Poisoning
Article | Year |
---|---|
Adjuvant Lipoic acid Injection in Sepsis treatment in China (ALIS study): protocol for a randomised, single-blind, placebo-controlled trial.
Topics: Humans; Intensive Care Units; Prognosis; Randomized Controlled Trials as Topic; Sepsis; Single-Blind | 2023 |
13 other studies available for thioctic acid and Blood Poisoning
Article | Year |
---|---|
Lipoic Acid and Fish Oil Combination Potentiates Neuroinflammation and Oxidative Stress Regulation and Prevents Cognitive Decline of Rats After Sepsis.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Catalase; Cells, Cultured; Cognitive Dysfunction; | 2020 |
Alpha-lipoic acid attenuates acute neuroinflammation and long-term cognitive impairment after polymicrobial sepsis.
Topics: Acute Disease; Animals; Antioxidants; Brain; Cognitive Dysfunction; Coinfection; Inflammation; Infla | 2017 |
Autophagy Enhancing Contributes to the Organ Protective Effect of Alpha-Lipoic Acid in Septic Rats.
Topics: Animals; Apoptosis; Autophagy; Cytokines; Disease Models, Animal; Inflammation; Male; NF-kappa B; Pr | 2019 |
α-Lipoic acid protects mitochondrial enzymes and attenuates lipopolysaccharide-induced hypothermia in mice.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Electron Transport Complex III; Energy Metabolism; Fe | 2014 |
α-Lipoic acid prolongs survival and attenuates acute kidney injury in a rat model of sepsis.
Topics: Acute Kidney Injury; Animals; Antioxidants; Cecum; Ligation; Male; NF-kappa B; Punctures; Rats; Rats | 2014 |
Alpha-lipoic acid exerts anti-inflammatory effects on lipopolysaccharide-stimulated rat mesangial cells via inhibition of nuclear factor kappa B (NF-κB) signaling pathway.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cel | 2015 |
Alpha-lipoic acid prevents endotoxic shock and multiple organ dysfunction syndrome induced by endotoxemia in rats.
Topics: Animals; Antioxidants; Antithrombins; Aorta; Caspase 3; Disulfides; Endotoxemia; Enzyme Activation; | 2015 |
Alpha-Lipoic Acid Attenuates Oxidative Damage in Organs After Sepsis.
Topics: Animals; Antioxidants; Catalase; Cecum; Inflammation; Kidney; Lipid Peroxidation; Liver; Lung; Male; | 2016 |
Staphylococcus aureus Tissue Infection During Sepsis Is Supported by Differential Use of Bacterial or Host-Derived Lipoic Acid.
Topics: Adaptation, Physiological; Animals; Disease Models, Animal; Female; Mice; Mutagenesis, Site-Directed | 2016 |
Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injury.
Topics: Animals; Cytokines; E-Selectin; Energy Metabolism; Heterozygote; Lipopolysaccharides; Liver; Lung; M | 2009 |
The oxidative stress and the mitochondrial dysfunction caused by endotoxemia are prevented by alpha-lipoic acid.
Topics: Animals; Antioxidants; Endotoxemia; Female; Lipopolysaccharides; Mitochondria; Muscle, Skeletal; Nit | 2008 |
Alpha-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats.
Topics: Acute Lung Injury; Animals; Cecum; Disease Models, Animal; Interleukin-6; Ligation; Male; NF-kappa B | 2010 |
Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line, Tumor; Humans; Inflammation; Lipopolysac | 2007 |